Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13463950 | 1.00 | TLR4 (0.36) | TLR4 | |
| SCHEMBL13463954 | 0.95 | TLR4 (0.38) | TLR4 | |
| SCHEMBL13463948 | 0.91 | — | — | |
| SCHEMBL9979801 | 0.90 | CYP1A2 (0.39) | — | |
| SCHEMBL13463951 | 0.90 | CYP1A2 (0.39) | — | |
| SCHEMBL14867246 | 0.90 | TLR4 (0.32) | TLR4 | |
| SCHEMBL13464035 | 0.89 | CYP1A2 (0.34) | — | |
| SCHEMBL9999747 | 0.89 | CYP1A2 (0.34) | — | |
| SCHEMBL9979797 | 0.89 | CYP1A2 (0.34) | — | |
| SCHEMBL13463956 | 0.89 | CYP1A2 (0.40) | TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340328-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-26 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-20180223187-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2018-08-09 | — | — | US | disclosed |
| EP-2909286-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-11-22 | — | — | EP | disclosed |
| EP-2837671-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2017-10-25 | — | — | EP | disclosed |
| EP-2993216-B1 | COMPOUNDS AND LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| WO-2017102051-A1 | METHOD FOR MANUFACTURING A LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL MIXTURE | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017102053-A2 | CINNAMIC ACID DERIVATIVES | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
| EP-2628779-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-05-17 | — | — | EP | disclosed |
| WO-2017020998-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-09 | — | — | WO | disclosed |
| US-20150275088-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2015-10-01 | — | — | US | disclosed |
| EP-2837671-A2 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2015-02-18 | — | — | EP | disclosed |
| WO-2014094999-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014063777-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2014-05-01 | — | — | WO | disclosed |
| EP-2703472-A2 | Liquid crystalline medium | Merck Patent GmbH (DE) | 2014-03-05 | — | — | EP | disclosed |
| EP-2628779-A2 | Liquid-crystalline medium | Merck Patent GmbH (DE) | 2013-08-21 | — | — | EP | disclosed |
| EP-2222816-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-10-17 | — | — | EP | disclosed |
| WO-2012079676-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2012-06-21 | — | — | WO | disclosed |
| EP-1646703-B1 | LIQUID-CRYSTAL MEDIUM CONTAINING MONOFLUOROTERPHENYL COMPOUNDS | MERCK PATENT GMBH (DE) | 2010-03-17 | — | — | EP | disclosed |
| WO-2009080261-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667845-B2 | Liquid crystalline medium | NEFM, CCNI, MYT1 | TLR4 1405/4885 |
| US-20150275088-A1 | LIQUID-CRYSTALLINE MEDIUM | SOST, FES, VIM | TLR4 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.